EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr |
What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹132 Cr |
| Mar2023 | ₹404 Cr |
| Mar2022 | ₹310 Cr |
| Mar2021 | ₹222 Cr |
How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -6.26 | |
| Mar2024 | ₹132 Cr | -67.20 | |
| Mar2023 | ₹404 Cr | 30.25 | |
| Mar2022 | ₹310 Cr | 39.81 | |
| Mar2021 | ₹222 Cr | - | |
Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹37,890.7 Cr | 2% | 11.4% | 41.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 2% |
11.4% |
41.6% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses